CardioLogs ECG Analysis Platform vs iPredict Eye Screening

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS
by iHealthScreen

AI Verdict

Tool A is specifically designed for the AI-powered analysis of ECG data to detect and diagnose cardiac arrhythmias, making it ideal for cardiology and emergency medicine. In contrast, Tool B primarily offers AI-driven screening for retinal diseases, with an additional feature for predicting systemic disease risks, including heart attack, based on retinal images. While both utilize AI in cardiology-related applications and are cloud-based, they address different diagnostic pathways and utilize distinct data inputs.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your practice requires a highly accurate, AI-driven solution for comprehensive ECG data analysis across multiple monitoring devices. It is ideal for cardiologists, emergency departments, and internal medicine specialists who need to efficiently detect and diagnose various arrhythmias from Holter monitors, smartwatches, or ECG patches, with seamless cloud-based reporting and EHR integration.

View CardioLogs ECG Analysis Platform →

Choose iPredict Eye Screening if…

Choose iPredict Eye Screening if your primary care clinic or ophthalmology practice needs a rapid, non-invasive AI-powered tool for early detection of multiple retinal diseases like AMD, DR, and Glaucoma. This platform is particularly well-suited for high-volume screening environments and telemedicine, offering quick results and additional risk prediction for systemic conditions such as stroke and heart attack.

View iPredict Eye Screening →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform iPredict Eye Screening
Pricing Unknown Contact for pricing
Deployment Cloud-based Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

iPredict Eye Screening

Tool B explicitly highlights its ease of operation, non-invasive nature, and quick test completion and report generation times (under 5 minutes for the test, under 60 seconds for the report), directly addressing user experience and efficiency in a clinical setting. While Tool A emphasizes rapid and efficient analysis, it provides less direct detail on the user's interaction with the platform or device itself.

Clinical Value

iPredict Eye Screening

Tool B provides concrete accuracy metrics for its screenings (e.g., AMD sensitivity 86.86%, specificity 94.13%) and covers a broader range of conditions, including risk prediction for systemic diseases like stroke and heart attack, demonstrating a wider clinical impact. While Tool A is FDA-cleared and uses medical-grade AI for arrhythmia detection with reported reductions in false positives and analysis time, it lacks specific sensitivity/specificity metrics in the provided data for direct comparison.

Pricing & Value

iPredict Eye Screening

Tool B offers greater transparency by providing an estimated per-patient screening cost ($10-$20) and relating it to potential Medicare/commercial payor reimbursement, allowing for a clearer understanding of its economic value. Tool A's pricing model is less transparent, only stating 'pay per ECG' without any cost figures.

Enterprise Readiness

CardioLogs ECG Analysis Platform

Both tools demonstrate strong enterprise readiness with cloud deployment, EHR integration, FDA clearance, and HIPAA compliance. However, Tool A explicitly highlights ISO/IEC 27001 certified AWS servers and indicates a likely Business Associate Agreement (BAA), providing a stronger assurance of data security and compliance for enterprise deployments.

Innovation

iPredict Eye Screening

While both leverage AI, Tool B demonstrates broader innovation by extending its AI-powered screening beyond ophthalmology to include risk prediction for systemic diseases like stroke and heart attack from retinal images. Its integration with telemedicine and online health risk prediction systems also showcases a wider application of AI in healthcare.

Support & Docs

CardioLogs ECG Analysis Platform

Tool A, as a Philips solution, benefits from a more comprehensive and established support ecosystem, including a dedicated customer service center, in-platform support via a 'Help' menu, and a broader range of accessible documentation and educational resources. Tool B provides standard contact methods like email and phone but lacks the depth of support infrastructure offered by a larger entity like Philips.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform iPredict Eye Screening
Name CardioLogs ECG Analysis Platform iPredict Eye Screening
Company Cardiologs Technologies (now part of Philips) iHealthScreen
Tagline Reinventing cardiology diagnostics with medical-grade AI and cloud technology. AI-powered screening tools for early detection of retinal and systemic diseases.
Primary Categories Cardiology AI Cardiology AI, Neurology AI, Ophthalmology AI
Key Features (Examples) AI-Powered ECG Analysis (Deep Neural Networks), Cloud-Based Platform, Multi-Device Compatibility (Holter, smartwatches, ECG patches) AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma, Electronic Health Record (EHR) Solutions, AI-Based Telemedicine Service

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and iPredict Eye Screening.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CardioLogs ECG Analysis Platform is designed for rapid, accurate, and efficient AI-powered analysis of ECG data to aid in arrhythmia detection and diagnosis, serving specialties like Cardiology, Emergency Medicine, and Internal Medicine. iPredict Eye Screening offers AI-powered screening for retinal diseases such as Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD) in patients aged 50 and older, and Glaucoma, along with risk prediction for systemic diseases, targeting Family Medicine, Internal Medicine, and Ophthalmology.
CardioLogs' AI analyzes ECG data to detect various arrhythmias, such as AFib and VT. iPredict's AI screens for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma, and also provides an online health risk prediction system for conditions like diabetes, stroke, and heart attack.
Both CardioLogs ECG Analysis Platform and iPredict Eye Screening offer integration capabilities with Electronic Health Record (EHR) systems. This feature allows for streamlined workflows and the incorporation of diagnostic or screening results directly into patient records.
Yes, CardioLogs ECG Analysis Platform offers real-time monitoring and analysis capabilities for ECG data. iPredict Eye Screening emphasizes rapid results, with tests completed in less than 5 minutes and reports generated in under 60 seconds.
AI Tool Finder
AI-powered search. Results may not be comprehensive.